Stock Analysis on Net
Stock Analysis on Net

Becton, Dickinson & Co. (NYSE:BDX)

Common Stock Valuation Ratios (Price Multiples)
Quarterly Data

Beginner level


Historical Valuation Ratios (Summary)

Becton, Dickinson & Co., historical price multiples (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Price to earnings (P/E) 95.62 75.45 90.00 65.09 83.38 66.87 72.88 408.36 105.60 206.04 49.63 59.56 30.05 28.94 36.65 32.09 43.18 41.64 45.52 38.75 27.56 24.05 22.89
Price to operating profit (P/OP) 56.20 43.34 49.82 40.02 29.43 29.40 30.27 43.37 47.87 95.72 67.53 34.59 40.06 21.15 20.05 25.02 22.42 27.98 26.60 29.46 26.74 19.97 17.53 16.89
Price to sales (P/S) 4.45 4.00 3.94 4.07 3.82 3.64 3.82 4.06 4.45 4.49 4.94 4.23 3.72 3.21 3.05 2.87 2.97 2.86 2.55 3.08 3.35 3.51 3.26 3.21
Price to book value (P/BV) 3.13 3.32 3.23 3.34 3.04 2.91 3.05 3.09 3.07 2.87 2.85 3.95 3.60 4.96 4.99 4.69 4.55 4.56 3.97 4.42 4.35 4.15 5.46 5.37 4.17 4.13 4.22

Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Becton, Dickinson & Co.’s P/E ratio decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 exceeding Q1 2020 level.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Becton, Dickinson & Co.’s P/OP ratio decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 exceeding Q1 2020 level.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Becton, Dickinson & Co.’s P/S ratio increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. Becton, Dickinson & Co.’s P/BV ratio increased from Q1 2020 to Q2 2020 but then decreased significantly from Q2 2020 to Q3 2020.

Price to Earnings (P/E)

Becton, Dickinson & Co., historical P/E calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
No. shares of common stock outstanding1 289,868,551 271,776,378 271,173,148 270,459,892 269,954,141 269,731,903 269,063,379 268,257,940 267,563,574 267,201,840 266,242,472 227,978,328 227,564,969 213,305,385 212,825,085 212,319,588 212,925,842 212,202,004 211,816,526 210,736,542 210,254,373 209,385,629 192,938,801 191,977,449 191,835,949 193,204,013 193,021,175
Selected Financial Data (US$)
Net income (loss) applicable to common shareholders (in millions) 277  145  240  125  413  (18) 562  (173) 556  (50) (174) 289  (165) 344  562  19  390  338  229  181  62  216  236  301  326  287  271 
Earnings per share (EPS)2 2.72 3.40 2.80 4.00 2.90 3.44 3.33 0.59 2.32 -0.37 1.10 4.52 3.34 6.16 6.15 4.60 5.34 3.82 3.25 3.30 3.88 5.15 5.96 6.17 0.00 0.00 0.00
Share price1, 3 259.61 256.25 252.25 260.40 242.14 229.80 242.41 242.04 245.10 227.13 227.52 224.23 198.90 185.28 177.97 168.48 171.53 164.84 135.25 150.12 150.19 142.01 143.32 141.26 116.88 113.49 110.94
Valuation Ratio
P/E ratio4 95.62 75.45 90.00 65.09 83.38 66.87 72.88 408.36 105.60 206.04 49.63 59.56 30.05 28.94 36.65 32.09 43.18 41.64 45.52 38.75 27.56 24.05 22.89
Benchmarks
P/E Ratio, Competitors5
Boston Scientific Corp. 13.56 11.72 11.86 51.90 42.77 28.42 33.06 73.07 89.21 363.19 354.70 44.70 46.56 83.30 96.19 362.11
Danaher Corp. 41.91 35.88 38.34 40.31 41.93 37.63 29.77 25.70 27.06 27.78 27.25 26.31 26.25 25.00 23.02 22.23 16.01 18.64 17.85
Intuitive Surgical Inc. 70.73 44.28 48.72 49.80 51.02 53.16 53.03 73.32 73.33 69.50 70.95 45.87 42.21 38.18 37.16 36.58 39.90 37.79 34.24
Medtronic PLC 25.38 31.86 32.75 28.78 25.11 57.38 41.16 37.80 37.82 21.55 26.35 29.96 28.24 23.20 32.64 33.17 43.49 47.09 37.49 40.56
Stryker Corp. 45.35 31.33 39.24 23.72 22.60 19.64 18.96 48.55 58.86 62.59 54.36 33.60 32.52 29.96 27.92 25.79 27.29 25.30 24.92
Thermo Fisher Scientific Inc. 44.19 35.50 33.36 33.89 31.08 35.11 35.19 36.71 39.27 37.52 37.66 33.39 30.36 30.83 30.45 29.02 31.09 29.03 26.19
UnitedHealth Group Inc. 16.88 19.91 20.48 17.79 17.98 17.93 21.09 21.18 20.91 20.02 20.77 23.90 23.24 22.18 21.73 20.76 22.06 20.88 18.18

Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).

1 Data adjusted for splits and stock dividends.

2 Q3 2020 Calculation
EPS = (Net income (loss) applicable to common shareholdersQ3 2020 + Net income (loss) applicable to common shareholdersQ2 2020 + Net income (loss) applicable to common shareholdersQ1 2020 + Net income (loss) applicable to common shareholdersQ4 2019) ÷ No. shares of common stock outstanding
= (277,000,000 + 145,000,000 + 240,000,000 + 125,000,000) ÷ 289,868,551 = 2.72

3 Closing price as at the filing date of Becton, Dickinson & Co.’s Quarterly or Annual Report.

4 Q3 2020 Calculation
P/E ratio = Share price ÷ EPS
= 259.61 ÷ 2.72 = 95.62

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Becton, Dickinson & Co.’s P/E ratio decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 exceeding Q1 2020 level.

Price to Operating Profit (P/OP)

Becton, Dickinson & Co., historical P/OP calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
No. shares of common stock outstanding1 289,868,551 271,776,378 271,173,148 270,459,892 269,954,141 269,731,903 269,063,379 268,257,940 267,563,574 267,201,840 266,242,472 227,978,328 227,564,969 213,305,385 212,825,085 212,319,588 212,925,842 212,202,004 211,816,526 210,736,542 210,254,373 209,385,629 192,938,801 191,977,449 191,835,949 193,204,013 193,021,175
Selected Financial Data (US$)
Operating income (loss) (in millions) 358  370  501  110  626  136  888  571  513  183  230  444  (223) 446  811  96  516  466  352  295  137  293  349  402  445  381  378 
Operating profit per share2 4.62 5.91 5.06 6.51 8.23 7.82 8.01 5.58 5.12 2.37 3.37 6.48 4.97 8.76 8.88 6.74 7.65 5.89 5.08 5.10 5.62 7.11 8.17 8.37 0.00 0.00 0.00
Share price1, 3 259.61 256.25 252.25 260.40 242.14 229.80 242.41 242.04 245.10 227.13 227.52 224.23 198.90 185.28 177.97 168.48 171.53 164.84 135.25 150.12 150.19 142.01 143.32 141.26 116.88 113.49 110.94
Valuation Ratio
P/OP ratio4 56.20 43.34 49.82 40.02 29.43 29.40 30.27 43.37 47.87 95.72 67.53 34.59 40.06 21.15 20.05 25.02 22.42 27.98 26.60 29.46 26.74 19.97 17.53 16.89
Benchmarks
P/OP Ratio, Competitors5
Boston Scientific Corp. 80.81 44.72 36.71 34.77 36.58 31.15 36.68 32.51 31.09 30.63 28.71 34.07 34.07 69.95 74.67 814.74
Danaher Corp. 43.09 35.22 34.47 29.44 30.85 26.85 23.18 20.95 21.72 22.58 22.48 22.35 21.13 20.83 21.37 18.48 18.09 19.87 17.27
Intuitive Surgical Inc. 71.30 43.68 48.89 50.00 49.12 51.89 49.87 48.90 50.69 46.82 44.40 41.74 35.53 31.07 28.93 28.50 31.46 30.10 27.24
Medtronic PLC 21.01 23.52 22.21 21.26 19.74 21.13 20.04 17.64 16.73 17.82 19.53 22.64 21.53 18.18 22.35 22.18 25.45 26.74 25.83 28.81
Stryker Corp. 33.20 24.04 30.13 32.94 33.22 27.96 26.55 23.52 25.45 27.41 24.21 26.70 25.11 22.99 21.23 19.87 21.42 20.73 19.27
Thermo Fisher Scientific Inc. 36.59 28.44 26.84 26.99 24.59 28.45 27.33 26.24 28.33 26.99 28.24 28.12 25.79 26.21 25.13 24.26 25.78 24.44 22.15
UnitedHealth Group Inc. 11.85 13.80 14.40 12.43 12.51 12.48 14.58 15.82 15.19 14.17 14.42 14.30 13.54 12.56 11.79 11.14 11.71 11.07 9.59

Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).

1 Data adjusted for splits and stock dividends.

2 Q3 2020 Calculation
Operating profit per share = (Operating income (loss)Q3 2020 + Operating income (loss)Q2 2020 + Operating income (loss)Q1 2020 + Operating income (loss)Q4 2019) ÷ No. shares of common stock outstanding
= (358,000,000 + 370,000,000 + 501,000,000 + 110,000,000) ÷ 289,868,551 = 4.62

3 Closing price as at the filing date of Becton, Dickinson & Co.’s Quarterly or Annual Report.

4 Q3 2020 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 259.61 ÷ 4.62 = 56.20

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Becton, Dickinson & Co.’s P/OP ratio decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 exceeding Q1 2020 level.

Price to Sales (P/S)

Becton, Dickinson & Co., historical P/S calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
No. shares of common stock outstanding1 289,868,551 271,776,378 271,173,148 270,459,892 269,954,141 269,731,903 269,063,379 268,257,940 267,563,574 267,201,840 266,242,472 227,978,328 227,564,969 213,305,385 212,825,085 212,319,588 212,925,842 212,202,004 211,816,526 210,736,542 210,254,373 209,385,629 192,938,801 191,977,449 191,835,949 193,204,013 193,021,175
Selected Financial Data (US$)
Revenues (in millions) 3,855  4,253  4,225  4,585  4,350  4,195  4,160  4,403  4,278  4,222  3,080  3,167  3,035  2,969  2,922  3,232  3,198  3,067  2,986  3,060  3,120  2,051  2,051  2,202  2,157  2,072  2,015 
Sales per share2 58.36 64.07 64.00 63.93 63.37 63.16 63.42 59.58 55.12 50.54 46.01 53.04 53.43 57.76 58.35 58.79 57.82 57.65 52.96 48.79 44.82 40.41 43.96 43.99 0.00 0.00 0.00
Share price1, 3 259.61 256.25 252.25 260.40 242.14 229.80 242.41 242.04 245.10 227.13 227.52 224.23 198.90 185.28 177.97 168.48 171.53 164.84 135.25 150.12 150.19 142.01 143.32 141.26 116.88 113.49 110.94
Valuation Ratio
P/S ratio4 4.45 4.00 3.94 4.07 3.82 3.64 3.82 4.06 4.45 4.49 4.94 4.23 3.72 3.21 3.05 2.87 2.97 2.86 2.55 3.08 3.35 3.51 3.26 3.21
Benchmarks
P/S Ratio, Competitors5
Boston Scientific Corp. 5.31 4.66 5.19 5.44 5.92 5.14 5.62 5.06 4.89 4.39 4.08 4.27 4.21 4.22 3.98 3.59 4.08 3.86 3.13
Danaher Corp. 7.48 6.34 6.29 5.14 5.43 4.67 3.97 3.62 3.74 3.77 3.70 3.52 3.32 3.35 3.48 3.05 2.94 3.34 2.91
Intuitive Surgical Inc. 18.44 13.33 15.01 15.41 15.28 15.83 16.06 16.36 17.01 16.16 14.96 13.83 12.01 10.69 10.11 10.06 10.69 9.70 8.46
Medtronic PLC 4.34 4.82 4.72 4.36 4.04 4.27 4.35 3.92 3.57 3.65 3.62 4.06 3.82 3.39 4.14 4.07 3.70 4.20 4.23 5.36
Stryker Corp. 5.16 4.53 5.49 5.59 5.65 4.98 4.95 4.52 4.88 5.01 4.46 4.93 4.62 4.29 4.06 3.93 4.18 4.07 3.61
Thermo Fisher Scientific Inc. 6.24 5.08 4.83 4.83 4.43 4.52 4.24 3.95 4.07 3.84 4.01 3.92 3.58 3.57 3.37 3.22 3.53 3.34 3.05
UnitedHealth Group Inc. 1.17 1.12 1.18 1.00 1.00 0.98 1.12 1.22 1.17 1.09 1.10 1.05 0.98 0.89 0.83 0.75 0.78 0.76 0.68

Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).

1 Data adjusted for splits and stock dividends.

2 Q3 2020 Calculation
Sales per share = (RevenuesQ3 2020 + RevenuesQ2 2020 + RevenuesQ1 2020 + RevenuesQ4 2019) ÷ No. shares of common stock outstanding
= (3,855,000,000 + 4,253,000,000 + 4,225,000,000 + 4,585,000,000) ÷ 289,868,551 = 58.36

3 Closing price as at the filing date of Becton, Dickinson & Co.’s Quarterly or Annual Report.

4 Q3 2020 Calculation
P/S ratio = Share price ÷ Sales per share
= 259.61 ÷ 58.36 = 4.45

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Becton, Dickinson & Co.’s P/S ratio increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.

Price to Book Value (P/BV)

Becton, Dickinson & Co., historical P/BV calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
No. shares of common stock outstanding1 289,868,551 271,776,378 271,173,148 270,459,892 269,954,141 269,731,903 269,063,379 268,257,940 267,563,574 267,201,840 266,242,472 227,978,328 227,564,969 213,305,385 212,825,085 212,319,588 212,925,842 212,202,004 211,816,526 210,736,542 210,254,373 209,385,629 192,938,801 191,977,449 191,835,949 193,204,013 193,021,175
Selected Financial Data (US$)
Shareholders’ equity (in millions) 24,022  20,951  21,202  21,081  21,497  21,310  21,403  20,994  21,358  21,152  21,247  12,948  12,587  7,963  7,583  7,633  8,033  7,666  7,223  7,164  7,253  7,159  5,068  5,053  5,378  5,315  5,078 
Book value per share (BVPS)2 82.87 77.09 78.19 77.95 79.63 79.00 79.55 78.26 79.82 79.16 79.80 56.79 55.31 37.33 35.63 35.95 37.73 36.13 34.10 34.00 34.50 34.19 26.27 26.32 28.03 27.51 26.31
Share price1, 3 259.61 256.25 252.25 260.40 242.14 229.80 242.41 242.04 245.10 227.13 227.52 224.23 198.90 185.28 177.97 168.48 171.53 164.84 135.25 150.12 150.19 142.01 143.32 141.26 116.88 113.49 110.94
Valuation Ratio
P/BV ratio4 3.13 3.32 3.23 3.34 3.04 2.91 3.05 3.09 3.07 2.87 2.85 3.95 3.60 4.96 4.99 4.69 4.55 4.56 3.97 4.42 4.35 4.15 5.46 5.37 4.17 4.13 4.22
Benchmarks
P/BV Ratio, Competitors5
Boston Scientific Corp. 3.46 3.64 4.02 5.83 6.33 5.53 6.33 5.91 6.00 5.79 5.26 4.97 5.07 5.14 4.96 4.52 5.22 4.58 3.70 3.92 3.56 3.57
Danaher Corp. 3.90 3.68 3.72 3.02 3.19 2.88 2.80 2.56 2.65 2.61 2.58 2.47 2.35 2.42 2.56 2.39 2.24 2.70 2.53 2.79 2.53 2.57
Intuitive Surgical Inc. 9.19 7.22 8.13 8.43 8.49 8.68 8.96 9.30 10.03 9.71 9.91 8.35 7.62 7.21 4.73 4.77 5.22 5.00 4.67 4.53 5.37 5.31
Medtronic PLC 2.60 2.94 2.87 2.66 2.48 2.62 2.59 2.31 2.11 2.10 2.14 2.40 2.27 1.96 2.34 2.25 2.08 2.09 1.86 2.04 3.79 3.72 3.25
Stryker Corp. 5.69 5.17 6.38 6.60 6.72 5.92 5.74 6.09 6.72 6.92 5.56 5.73 5.51 5.21 4.82 4.59 4.81 4.65 4.21 4.18 4.52 4.19
Thermo Fisher Scientific Inc. 5.48 4.56 4.16 4.15 3.83 4.02 3.75 3.51 3.55 3.24 3.30 3.14 3.07 3.07 2.86 2.67 2.92 2.76 2.42 2.50 2.69 2.55
UnitedHealth Group Inc. 4.53 4.81 4.92 4.32 4.40 4.37 4.89 5.32 5.13 4.72 4.59 4.55 4.37 4.01 3.98 3.61 3.75 3.57 3.12 3.35 3.51 3.39

Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).

1 Data adjusted for splits and stock dividends.

2 Q3 2020 Calculation
BVPS = Shareholders’ equity ÷ No. shares of common stock outstanding
= 24,022,000,000 ÷ 289,868,551 = 82.87

3 Closing price as at the filing date of Becton, Dickinson & Co.’s Quarterly or Annual Report.

4 Q3 2020 Calculation
P/BV ratio = Share price ÷ BVPS
= 259.61 ÷ 82.87 = 3.13

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company’s required rate of return and its actual rate of return. Becton, Dickinson & Co.’s P/BV ratio increased from Q1 2020 to Q2 2020 but then decreased significantly from Q2 2020 to Q3 2020.